Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
8-K
| Quarterly results
Docs:
|
"Assets Current assets Cash and cash equivalents $ 63,212 $ 21,929 Accounts receivable 46,553 54,826 Net investment in leases 13,219 16,130 Inventories 20,315 23,124 Income taxes receivable 1,779 — Prepaid expenses and other current assets 4,480 3,754 Total current assets 149,558 119,763 Non-current assets Property and equipment, net 5,771 6,077 Right of use operating lease assets 20,041 21,322 Intangible assets, net 48,559 50,375 Goodwill 31,063 31,063 Accounts receivable, non-current 15,430 23,061 Other non-current assets 3,306 3,335 Total non-current assets 124,170 135,233 Total assets $ 273,728 $ 254,996 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 9,296 $ 9,984 Note payable 2,968 2,968 Earn-out, current 9,280 13,050 Accrued payroll and related taxes 13,80..." |
|
05/08/2023 |
8-K
| Quarterly results |
11/07/2022 |
8-K
| Quarterly results
Docs:
|
"Third Quarter Revenue Increased 24% Year-Over-Year; First Nine Months Revenue Increased 18% Year-Over-Year MINNEAPOLIS, MN, November 7, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Summary: ● Total revenue increased 24% year-over-year to $65.3 million, compared to $52.5 million in third quarter 2021. ● Total revenue in third quarter 2022 included $11.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021, compared to $0.9 million of revenue in third qu..." |
|
08/01/2022 |
8-K
| Quarterly results
Docs:
|
"Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS, MN, August 1, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the second quarter and six months ended June 30, 2022. Second Quarter 2022 Summary: ● Total revenue increased 17% year-over-year to $59.6 million, compared to $51.1 million in second quarter 2021. ● Total revenue in second quarter 2022 included $8.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021. ● Operating loss of $4.1 million, compared to $0.1 m..." |
|
02/22/2022 |
8-K
| Quarterly results
Docs:
|
"Fourth Quarter Revenue Increased 4% Year-Over-Year; Full Year Revenue Increased 11% Year-over-Year MINNEAPOLIS, MN, February 22, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Summary: ● Total revenue increased 4% year-over-year to $61.7 million, compared to $59.2 million in fourth quarter 2020. ● Total revenue in fourth quarter 2021 included $4.3 million of revenue from the AffloVest respiratory therapy business, acquired on September 8, 2021. ● Operating income of $3.8 million, compared to operating income of $7.0 million in..." |
|
11/08/2021 |
8-K
| Quarterly results |
08/02/2021 |
8-K
| Quarterly results
Docs:
|
"Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS, MN, August 2, 2021 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the second quarter and six months ended June 30, 2021. Second Quarter 2021 Summary: ● Total revenue increased 45% year-over-year to $51.1 million, compared to $35.1 million in second quarter 2020. ● Operating loss of $0.1 million, compared to operating loss of $8.0 million in second quarter 2020. ● Net income of $1.3 million, compared to net loss of $13.9 million in second quarter 2020. ● Adjusted EBITDA of $4.1 million, compared to Adjusted EBITDA lo..." |
|
02/23/2021 |
8-K
| Quarterly results |
11/02/2020 |
8-K
| Quarterly results
Docs:
|
"Third Quarter Revenue Decreased 1% Year-Over-Year; Flat Year-Over-Year on an Operational Basis First Nine Months Revenue Decreased 3% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS, MN, November 2, 2020 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the third quarter and nine months ended September 30, 2020. Third Quarter 2020 Summary: ● Total revenue decreased 1% year-over-year, to $49.1 million, compared to $49.6 million in third quarter 2019. o Excluding the contribution to third quarter 2019 revenue related to the Company’s adoption of ASC 842, third quarter 2020 revenue reflects a flat year-over-year change on an op..." |
|
08/03/2020 |
8-K
| Quarterly results |
05/04/2020 |
8-K
| Quarterly results |
02/26/2020 |
8-K
| Quarterly results |
11/04/2019 |
8-K
| Quarterly results |
08/05/2019 |
8-K
| Quarterly results |
05/06/2019 |
8-K
| Quarterly results |
02/28/2019 |
8-K
| Quarterly results |
11/05/2018 |
8-K
| Quarterly results |
08/06/2018 |
8-K
| Quarterly results |
05/07/2018 |
8-K
| Quarterly results |
02/26/2018 |
8-K
| Quarterly results |
11/07/2017 |
8-K
| Quarterly results |
08/07/2017 |
8-K
| Quarterly results |
05/08/2017 |
8-K
| Form 8-K - Current report |
02/27/2017 |
8-K
| Form 8-K - Current report |
11/10/2016 |
8-K
| Form 8-K - Current report |
09/07/2016 |
8-K
| Quarterly results |
|
|